Expertise in

conditions

Shabir A. Madhi

Johannesburg, GT, ZA

Expertise in

conditions

Johannesburg, GT, ZA

Overview

Shabir Madhi practices practicing medicine in Johannesburg, South Africa.

Mr. Madhi is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Streptococcal Group B Infection, Strep Throat, Parainfluenza, and Flu.

He is actively involved in clinical research, co-authoring 655 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Johannesburg, GT, South Africa

Other Locations

University Of Cape Town, Cape Town, WC, South Africa

Parktown, GT, South Africa

South Africa, WC, South Africa

University Of Cape Town, Cape Town, Stellenbosch, WC, South Africa

South Africa

University Of Cape Town, Cape Town, Centurion, GT, South Africa

St John Eye Hospital, Soweto, GT, South Africa

St John Eye Hospital/Chris Hani Baragwanath Academic Hospital, Chris Hani, FS, South Africa

Pretoria, GT, South Africa

Johannesburg South, GT, South Africa

Sandringham, GT 2131, South Africa

Durban, ZN, South Africa

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age

Enrollment Status: Terminated

Publish Date: February 20, 2025

Intervention Type: Biological, Drug

Study Drug: RSV Maternal vaccine

Study Phase: Phase 3

Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting

Enrollment Status: Completed

Publish Date: May 28, 2024

A Phase 2A/B, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in South African Adult Subjects Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV

Enrollment Status: Completed

Publish Date: February 17, 2022

Intervention Type: Other, Biological

Study Drug: SARS-CoV-2 rS+Matrix-M1 Adjuvant

Study Phase: Phase 2

A Phase II, Randomised, Observer-blind, Placebo Controlled Multi-country Study to Assess the Safety, Reactogenicity and Immunogenicity of a Single Intramuscular Dose of GSK Biologicals' Investigational RSV Maternal Unadjuvanted Vaccine (GSK3888550A), in Healthy Pregnant Women Aged 18 to 40 Years and Infants Born to Vaccinated Mothers

Enrollment Status: Completed

Publish Date: December 13, 2021

Intervention Type: Drug, Biological

Study Phase: Phase 2

Establishing a Sero-correlate of Protection Against Invasive Group B Streptococcus Disease in Newborns and Young Infants Aged <=90 Days

Enrollment Status: Completed

Publish Date: September 13, 2018

View 4 Less Clinical Trials

654 Total Publications

Clesrovimab, a monoclonal antibody for the prevention of respiratory syncytial virus disease in infants: a drug profile.

Journal: Expert review of respiratory medicine

Published: September 03, 2026

View All 654 Publications

Frequently Asked Questions about Shabir A. Madhi

Is Shabir A. Madhi a top-rated expert for Streptococcal Group B Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Shabir A. Madhi is classified as an Elite expert for Streptococcal Group B Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shabir A. Madhi participate in research or clinical trials?

Yes. Shabir A. Madhi has published 654 articles and abstracts on conditions like Streptococcal Group B Infection. You can view a list of Shabir A. Madhi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Madhi's expertise for a condition

ConditionClose